Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Imperva, Inc. (IMPV) on Behalf of Stockholders and Encourages IMPV Investors to Contact the Firm

Oct 11, 2018


NEW YORK, -- Bragar Eagel & Squire, P.C. is investigating potential claims against Imperva, Inc. (NASDAQ: IMPV) on behalf of stockholders concerning the proposed acquisition of the company by Thoma Bravo, LLC.

Pursuant to the proposed transaction, announced on October 10, 2018 and valued at $2.1 billion, Imperva stockholders will receive $55.75 in cash for each share of Imperva common stock owned.  The investigation focuses on whether Imperva and its board of directors violated the federal securities laws and/or breached their fiduciary duties to the Company’s stockholders by failing to conduct a fair process and whether and by how much the proposed transaction undervalues the Company.

If you own Imperva shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at, or telephone at (212) 308-1869, or by filling out this contact form.  There is no cost or obligation to you.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation.  For additional information concerning our investigation of Imperva please go to  For additional information about Bragar Eagel & Squire, P.C. please go to


Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 308-1869

Tags: Wire, Legal Newswire, United States, English

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.